GENE ONLINE|News &
Opinion
Blog

Roche
Roche Reports Strong Mid-Year Results and Robust Pipeline Advances
2024-08-06
Roche Reports Positive Clinical Trial Results for Two Diabetes-Related Eye Disease Therapies
2024-07-19
Roche Secures CE Mark for AI-Powered Glucose Monitoring Solution, Enhancing Diabetes Care with Predictive Insights
2024-07-11
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Reviewing the Market Trends in the Antibody-Drug Conjugate Development: A Focus on Roche, Sanofi, BMS, Seagen, and BioNTech
2024-01-05
GeneOnline’s Weekly News Highlights: Oct 22-Oct 27
2023-10-31
Roche Could Set New DLBCL Treatment Standard with First-Line Polivy Indication
2023-04-19
Roche’s Polivy Wins Support From FDA Adcom For Treating B-Cell Cancer
2023-03-10
Roche Returns Gavreto Rights To Blueprint After Ditching Collaboration
2023-02-24
Roche’s Vision Loss Drug Clocks Two Phase 3 Wins In Macular Edema
2023-02-13
Belharra Therapeutics Exits Stealth With $130 Million And A Genentech Deal
2023-01-05
Roche’s Lunsumio Lands FDA Approval for Pretreated Follicular Lymphoma
2022-12-26
Canada Authorizes Roche’s Polivy as First-Line Lymphoma Treatment
2022-11-27
Roche’s Gantenerumab Fails Trials In Alzheimer’s Disease
2022-11-15
Roche Clocks Clinical Win as it Eyes Additional Vabysmo Indication
2022-10-27
1 2 3 4 7
LATEST
The Targeted Strike – ADCs and Bispecifics Delivering Precision Payloads in Modern Oncology
2026-04-15
Researchers Develop New Method to Detect Extraterrestrial Life by Analyzing Patterns Across Planetary Populations
2026-04-15
Early Patient Involvement in Drug Development Linked to Reduced Costs and Faster Timelines
2026-04-15
One in Four U.S. Adults Turns to AI Tools for Health Care Advice
2026-04-15
Policy, Pricing, and Power: Why Europe’s Biotech Future Depends on Openness, Not Overregulation
2026-04-14
Vitiligo: Causes, Life-Changing Impacts, Treatment Challenges, and Breakthrough New Drugs
2026-04-14
Chris Chen Presents Faraday Future AI Robotics Advancements at Harvard Science Center
2026-04-14
Scroll to Top